Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIGB.L Regulatory News (SIGB)

  • There is currently no data for SIGB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

9 Aug 2017 07:00

RNS Number : 4529N
Sherborne Investors (Guernsey)B Ltd
09 August 2017
 

 

Sherborne Investors (Guernsey) B Limited

 

Interim Report and Unaudited Condensed Consolidated Financial Statements

For the period from 1 January 2017 to 30 June 2017

 

 

Company Summary

 

The Company

Sherborne Investors (Guernsey) B Limited (the "Company") is a Guernsey domiciled limited company and its shares are admitted to trading on the London Stock Exchange's Specialist Fund Segment ("SFS"). The Company was incorporated on 8 November 2012. The Company commenced dealings on SFS on 7 May 2013.

Investment Objective and Policy

The Company's investment objective, through its investment in the Investment Partnership, is to realise capital growth from investment in a target company identified by the Investment Manager, with the aim of generating a significant capital return for Shareholders.

 

The Company's investment policy is to invest through its investment in a company which is publicly quoted, most likely on a UK stock exchange, which it considers to be undervalued as a result of operational deficiencies and which it believes can be rectified by the Investment Manager's active involvement, thereby increasing the value of the investment. The Company will only invest in one target company at a time.

Investment Manager

The General Partner and the Investment Partnership have appointed Sherborne Investors Management (Guernsey) LLC to provide investment management services to the Investment Partnership.

Chairman's Statement

 

During the period the Company continued to pursue its investment strategy through its shareholding in Electra Private Equity PLC ("Electra").

 

As at 30 June 2017, the net asset value attributable to shareholders of the Company was £159.5 million (December 2016: £487.5 million) or 50.70 pence per share (December 2016: 154.99 pence per share) (see note 12). The Company's net asset value was based on the closing price of 1,755 pence as at 30 June 2017 for the shares of Electra. As at the period end SIGB, LP held approximately 29.90% of Electra through ordinary shares. The ownership level remains the same at the date of this letter.

 

The principal risks and uncertainties of the Company are in relation to performance risk, market risk, and relationship risk. These are unchanged from 31 December 2016, and further details may be found in the Directors' Strategic Report within the Annual Report and Consolidated Financial Statements of the Company for the year ended 31 December 2016. The Directors will continue to assess the principal risks and uncertainties relating to the Company for the remaining six months of the year but expect these to remain unchanged.

 

Electra has realised a significant number of its investments during the past 12 months, resulting in the accumulation of excess cash balances. Electra distributed £1.35 billion of this excess to shareholders through dividends in May and July 2017. Following receipt of the distributions from Electra, the Company paid two dividends to its shareholders. The first dividend of 87.00 pence per share was paid on 19 May 2017 to shareholders of record on 18 April 2017 and the second of 30.00 pence per share, was paid on 28 July 2017 to shareholders of record on 23 June 2017. I am pleased to report that these two dividends represent a return of £368 million to shareholders during 2017.

 

On 27 February 2017, there was a £5 million partial repayment of the revolving loan facility with HSBC Bank plc (the "Facility"). Following receipt of the initial Electra dividend, on 11 May 2017 the Company repaid the remaining £15 million balance and cancelled the Facility.

 

On 1 June 2017 Electra's internal executive management assumed responsibilities from the former outsourced investment manager. Electra confirmed that Phase II of the Strategic Review would commence and would be announced in the fourth quarter of 2017. Electra noted that, giving effect to the two dividends paid, Electra's net asset value per share was 2,009 pence, of which 1,009 pence was in net cash balances.

 

Pursuant to its existing authority, the Investment Manager may sell, short or otherwise dispose of all or a part of such shares held in Electra or purchase additional securities at any time.

 

Details of Related Party Transactions are contained in Note 15 of the Notes to the Condensed Consolidated Financial Statements for the period ended 30 June 2017.

 

The Company intends to continue to pursue its strategy as set out in its prospectus.

 

We are grateful for your continued support and will keep you informed of the status of our investment as it develops.

 

Responsibility statement

 

We confirm that to the best of our knowledge:

• the condensed set of financial statements has been prepared in accordance with IAS 34 'Interim Financial Reporting';

• The Interim Report, comprising the Chairman's Statement, meets the requirements of an interim management report and includes a fair review of information required by:

o DTR 4.2.7R of the UK Disclosure and Transparency Rules, being an indication of important events that have occurred during the period from 1 January 2017 to 30 June 2017 and their impact on the Condensed Consolidated Financial Statements, and a description of the principal risks and uncertainties for the remaining six months of the year; and

o DTR 4.2.8R of the UK Disclosure and Transparency Rules, being related party transactions that have taken place in the period from 1 January 2017 to 30 June 2017 and that have materially affected the financial position or performance of the Company during that period, and any material changes in the related party transactions disclosed in the last Annual Report; and

• The Condensed Consolidated Financial Statements give a true and fair view of the assets, liabilities, financial position and result of the Company as required by DTR 4.2.4R of the UK Disclosure.

 

Going Concern

 

Under the UK Corporate Governance Code and applicable regulations, the Directors are required to satisfy themselves that it is reasonable to assume that the Company is a going concern.

 

The Directors have undertaken a rigorous review of the Company's ability to continue as a going concern including reviewing the on-going cash flows and the level of cash balances as of the reporting date as well as taking forecasts of future cash flows into consideration.

 

Based on the sufficient cash reserves as at 30 June 2017 and the Facility being repaid, the Directors are of the opinion that the Group has adequate resources to continue its operational activities for the foreseeable future.

 

After making enquiries of the Investment Manager and the Administrator, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt a going concern basis in preparing these unaudited Condensed Consolidated Financial Statements.

 

Independent Auditor's Review Report to the Members of Sherborne Investors (Guernsey) B Limited

 

We have been engaged by Sherborne Investors (Guernsey) B Limited ("the Company") to review the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2017 which comprises the Condensed Consolidated Statement of Comprehensive Income, the Condensed Consolidated Statement of Financial Position, the Condensed Consolidated Statement of Changes in Equity, the Condensed Consolidated Statement of Cash Flows and related notes 1 to 16. We have read the other information contained in the interim financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.

 

This report is made solely to the Company in accordance with International Standard on Review Engagements (UK and Ireland) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Auditing Practices Board. Our work has been undertaken so that we might state to the Company those matters we are required to state to it in an independent review report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company, for our review work, for this report, or for the conclusions we have formed.

 

Directors' responsibilities

 

The half-yearly financial report is the responsibility of, and has been approved by, the Directors. The Directors are responsible for preparing the half-yearly financial report in accordance with the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority.

 

As disclosed in Note 1, the annual financial statements of the Company are prepared in accordance with IFRSs as adopted by the European Union. The condensed set of financial statements included in this interim financial report has been prepared in accordance with International Accounting Standard 34, "Interim Financial Reporting," as adopted by the European Union.

 

Our responsibility

 

Our responsibility is to express to the Company a conclusion on the condensed set of financial statements in the half-yearly financial report based on our review.

 

Scope of review

 

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

 

Conclusion

 

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the period ended 30 June 2017 is not prepared, in all material respects, in accordance with International Accounting Standard 34 as adopted by the European Union and the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority.

 

Condensed Consolidated Statement of Comprehensive Income (Unaudited)

 

For the period from 1 January 2017 to 30 June 2017

 

1 January 2017 to

1 January 2016 to

1 January 2016 to

30 June 2017

30 June 2016

31 December 2016

(audited)

Notes

£

£

£

£

£

£

Income

1(e)

Unrealised (loss)/gain on investments held at fair value through profit or loss

1(d), 5

(345,302,046)

(12,298,863)

116,586,481

Dividend income

7

402,883,792

13,868,201

26,436,895

Bank interest income

13,032

9,148

13,455

57,594,778

1,578,486

143,036,831

Expenses

1(f)

Professional fees

109,270

150,137

760,511

 

Trading and custodian fees

2,861

56,146

56,445

 

Administrative fees

132,899

135,468

271,316

 

Other fees

87,489

146,661

141,363

 

Management fees

15

2,593,165

2,029,387

4,368,592

 

Finance costs

1(g)

278,221

1,116,295

1,887,638

 

Directors' fees

2, 15

58,750

55,000

110,000

 

(3,262,655)

(3,689,094)

(7,595,865)

Consolidated comprehensive income/(loss) for the period/year

54,332,123

(2,110,608)

135,440,966

Income/(loss) attributable to:

Shareholders

39,986,810

(2,054,023)

105,904,742

Non-controlling interest

1(b), 15

14,345,313

(56,585)

29,536,224

Weighted average number of shares outstanding

4

314,547,259

314,547,259

314,547,259

Basic and diluted earnings per share (pence) attributable to shareholders

4

12.71

(0.65)

33.67

All revenue and expenses are derived from continuing operations.

Although not required by IAS 34 - 'Interim Financial Reporting', the comparative figures for the preceding year and the related notes have been included on a voluntary basis.

 

The accompanying notes form an integral part of these consolidated financial statements.

 

Condensed Consolidated Statement of Financial Position (Unaudited)

 

As at 30 June 2017

 

30 June 2017

30 June 2016

31 December 2016

 

(audited)

 

Notes

£

£

£

£

£

£

 

Non-current Assets

 

Financial assets at fair value through profit or loss

1(d), 5

200,878,809

416,901,826

545,824,128

 

200,878,809

416,901,826

545,824,128

 

Current Assets

 

Prepaid expenses

6

34,355

62,185

27,534

 

Dividend receivable

7

104,434,426

-

12,568,695

 

Cash and cash equivalents

1(i), 8

5,612,798

10,918,336

4,852,217

 

110,081,579

10,980,521

17,448,446

 

Current Liabilities

 

Trade and other payables

9

(124,217)

(207,621)

(405,377)

Dividend payable

 13

(94,364,178)

-

-

Loan payable

 10

-

(20,000,000)

-

(94,488,395)

(20,207,621)

(405,377)

Net Current Assets/(Liabilities)

15,593,184

(9,227,100)

17,043,069

 

Non-Current Liabilities

 

Loan payable

10

-

-

(20,000,000)

 

Net Assets

216,471,993

407,674,726

542,867,197

 

Capital and Reserves

 

Called up share capital and share premium

11

302,696,145

302,696,145

302,696,145

 

Retained reserves

(143,208,378)

79,225,441

184,825,104

 

Equity attributable to the Company

159,487,767

381,921,586

487,521,249

 

Non-controlling interest

1(b), 15

56,984,226

25,753,140

55,345,948

 

Total Equity

216,471,993

407,674,726

542,867,197

 

 

NAV Per Share attributable to the Company

12

50.70p

121.42p

154.99p

 

 

The Condensed Consolidated Financial Statements were approved by the Board of Directors for issue on 8 August 2017.

 

Although not required by IAS 34 - 'Interim Financial Reporting', the comparative figures for the preceding year and the related notes have been included on a voluntary basis.

 

The accompanying notes form an integral part of these consolidated financial statements.

 

Condensed Consolidated Statement of Changes in Equity (Unaudited)

 

For the period from 1 January 2017 to 30 June 2017

Share Capital

and Share

Premium

Retained

Reserves

Non-

Controlling

Interest

Total

Equity

Notes

£

£

£

£

Balance at 1 January 2017

302,696,145

184,825,104

55,345,948

542,867,197

Total comprehensive income for period

-

51,903,345

2,428,778

54,332,123

Incentive allocation

15, 1(m)

-

(11,916,535)

11,916,535

-

Dividends paid and accrued

13

-

(368,020,292)

-

(368,020,292)

Distribution

-

-

(12,707,035)

(12,707,035)

Balance at 30 June 2017

302,696,145

(143,208,378)

56,984,226

216,471,993

 

Share Capital

and Share

Premium

Retained

Reserves

Non-

Controlling

Interest

Total

Equity

Notes

£

£

£

£

Balance at 1 January 2016

302,696,145

85,997,672

26,076,772

414,770,589

Total comprehensive loss for the period

-

(2,025,096)

(85,512)

(2,110,608)

Incentive allocation

15, 1(m)

-

(28,927)

28,927

-

Dividends paid

-

(4,718,208)

-

(4,718,208)

Distribution

-

-

(267,047)

(267,047)

Balance at 30 June 2016

302,696,145

79,225,441

25,753,140

407,674,726

 

Share Capital

and Share

Premium

Retained

Reserves

Non-

Controlling

Interest

Total

Equity

Notes

£

£

£

£

Balance at 1 January 2016

302,696,145

85,997,672

26,076,772

414,770,589

Total comprehensive income for the period

-

129,393,684

6,047,282

135,440,966

Incentive allocation

15, 1(m)

-

(23,488,942)

23,488,942

-

Dividends paid

-

(7,077,310)

-

(7,077,310)

Distribution

-

-

(267,048)

(267,048)

Balance at 31 December 2016

302,696,145

184,825,104

55,345,948

542,867,197

Although not required by IAS 34 - 'Interim Financial Reporting', the comparative figures for the preceding year and the related notes have been included on a voluntary basis.

 

The accompanying notes form an integral part of these consolidated financial statements.

 

Condensed Consolidated Statement of Cash Flows (Unaudited)

 

For the period from 1 January 2017 to 30 June 2017

Notes

1 January 2017

to 30 June 2017

£

1 January 2016

to 30 June 2016

£

 

1 January 2016 to 31 December 2016

£ (audited)

Net cash flow from operating activities

402,109,824

10,460,622

7,557,600

Investing activities

Purchase of investments

5

(356,727)

(2,405,001)

(2,441,959)

Bank interest income

13,032

9,148

13,455

Net cash flows used in investing activities

(343,695)

(2,395,853)

(2,428,504)

Financing activities

Dividends paid

13

(368,020,292)

(4,718,208)

(7,077,310)

Loan repayments

10

(20,000,000)

-

-

(Distributions)/Commitments to/from non-controlling interest

15

(12,707,035)

(267,047)

(267,048)

Finance costs

(278,221)

(1,095,828)

(1,867,171)

Net cash flows used in financing activities

(401,005,548)

(6,081,083)

(9,211,529)

Net movement in cash and cash equivalents

760,581

1,983,686

(4,082,433)

Cash and cash equivalents at beginning of period/year

4,852,217

8,934,650

8,934,650

Cash and cash equivalents at period/year end

5,612,798

10,918,336

4,852,217

Net cash flow from operating activities

Total consolidated comprehensive income/(loss) for the period/year

54,332,123

(2,110,608)

135,440,966

Fair value movement on financial assets

5

345,302,046

12,298,863

(116,586,481)

Movement in prepaid expenses and

income receivable

(91,872,552)

(30,295)

(12,564,339)

Movement in trade and other payables

94,083,018

(804,485)

(606,729)

Bank interest income

(13,032)

(9,148)

(13,455)

Finance costs

278,221

1,116,295

1,887,638

Net cash flow from operating activities

402,109,824

10,460,622

7,557,600

 

 

Although not required by IAS 34 - 'Interim Financial Reporting', the comparative figures for the preceding year and the related notes have been included on a voluntary basis.

 

The accompanying notes form an integral part of these consolidated financial statements.

 

Notes to the Condensed Consolidated Financial Statements

 

For the period from 1 January 2017 to 30 June 2017

 

1. Summary of significant accounting policies

 

Reporting entity

 

Sherborne Investors (Guernsey) B Limited (the ''Company") is a closed-ended investment company with limited liability formed under The Companies (Guernsey) Law, 2008. The Company was incorporated and registered in Guernsey on 8 November 2012. The Company deals on the London Stock Exchange's Specialist Fund Segment ("SFS"). The Company's registered office is 1 Royal Plaza, Royal Avenue, St Peter Port, Guernsey GY1 2HL. The "Group" is defined as the Company and its subsidiary, SIGB, LP.

 

Basis of preparation

 

The Unaudited Condensed Consolidated Financial Statements of the Group have been prepared in accordance with International Financial Reporting Standards ("IFRS") as adopted by the European Union and in accordance with International Accounting Standard 34, 'Interim Financial Reporting' ('IAS 34'), together with applicable legal and regulatory requirements of Guernsey law. The same accounting policies have been applied as in the last audited accounts. The Directors have taken the exemption in Section 244 of The Companies (Guernsey) Law, 2008 (as amended) and have therefore elected to only prepare Consolidated Financial Statements for the period.

 

These Condensed Consolidated Financial Statements have been prepared on the historical cost basis, as modified by the measurement at fair value of investments.

 

Going concern

 

Under the UK Corporate Governance Code and applicable regulations, the Directors are required to satisfy themselves that it is reasonable to assume that the Company is a going concern.

 

The Directors have undertaken a rigorous review of the Company's ability to continue as a going concern including reviewing the on-going cash flows and the level of cash balances as of the reporting date as well as taking forecasts of future cash flows into consideration and are of the opinion that the Group has adequate resources to continue its operational activities for the foreseeable future.

 

After making enquiries of the Investment Manager and the Administrator, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt a going concern basis in preparing these unaudited Condensed Consolidated Financial Statements.

 

Critical accounting judgments and key sources of estimation uncertainty

 

The preparation of the Group's Condensed Consolidated Financial Statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and contingencies at the date of the Group's Condensed Consolidated Financial Statements and revenue and expenses during the reported period. Actual results could differ from those estimated.

 

As more fully described in Note 15, "Related Party Transactions", the Special Limited Partner is entitled to receive an incentive allocation once aggregate distributions to Partners of the Investment Partnership exceed a certain level. The basis of the incentive calculation differs depending on how the investment in the Selected Target Company is ultimately characterized (i.e, as a Turnaround or Stake Building Investment). Otherwise there are no significant estimates utilised for the preparation of the Group's Condensed Consolidated Financial Statements as at 30 June 2017 due to the nature of the activities that have occurred in this period, together with the sole investment held by the Group being quoted on the London Stock Exchange.

 

Adoption of new and revised standards

(i) Amendments early adopted by the Company:

There were no standards, amendments and interpretations adopted early by the Company.

(ii) Standards, amendments and interpretations endorsed by the European Union ('EU') that are in issue but not yet effective:

 

New standards

Effective date

IFRS 9

Financial Instruments - Classifications and Measurement

1 January 2018

IFRS 15

Revenue from Contracts with Customers

1 January 2018

 

Revised and amended standards

Effective date

IFRS 7/9

Mandatory Effective Date and Transition Disclosure (amended)

1 January 2018

 

Unless stated otherwise, the Directors do not consider the adoption of new and revised Accounting Standards and Interpretations to have a material impact.

 

a. Basis of consolidation

 

The Condensed Consolidated Financial Statements incorporate the Financial Statements of the Company and an entity controlled by the Company (its subsidiary). Control is achieved where the Company has the power to govern the financial and operating policies of an investee entity so as to obtain benefits from its activities.

 

Non-controlling interests in the net assets of the consolidated subsidiary are identified separately from the Group's equity therein. Non-controlling interests consist of the amount of those interests at the date of the original business combination and the non-controlling entities' share of changes in equity since the date of the combination. Losses applicable to the non-controlling entities in excess of their interest in the subsidiary's equity are allocated against their interests to the extent that this would create a negative balance.

 

Where necessary, adjustments are made to the financial statements of the subsidiary to bring the accounting policies used into line with those used by the Group.

 

All intra-group transactions, balances and expenses are eliminated on consolidation.

 

The Company owns approximately 95.55% (2016: 95.55%) of the capital interest in SIGB, LP. Whilst the General Partner of SIGB, LP, Sherborne Investors (Guernsey) GP, LLC, a company registered in Delaware, USA, is responsible for directing the day to day operations of SIGB, LP, the Company, through its majority interest in SIGB, LP, has the ability to approve the proposed investment of SIGB, LP and to remove the General Partner. Hence, the Company has consolidated SIGB, LP in its financial statements.

 

b. Non-controlling interest

 

The interest of non-controlling parties in the subsidiary is measured at the minority's proportion of the net fair value of the assets, liabilities and contingent liabilities recognised.

 

c. Functional currency

 

Items included in the Condensed Consolidated Financial Statements of the Group are measured using the currency of the primary economic environment in which the entity operates ("the functional currency"). The Consolidated Financial Statements are presented in Pound Sterling (£), which is the Group's functional and presentational currency. Transactions in currencies other than £ are translated at the rate of exchange ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the date of the Consolidated Statement of Financial position are retranslated into £ at the rate of exchange ruling at that date. Exchange differences are reported in the Consolidated Statement of Comprehensive Income.

 

d. Financial assets at fair value through profit or loss

Investments, including equity and loan investments in associates, are designated as fair value through profit or loss in accordance with International Accounting Standard 39 ("IAS 39") ''Financial Instruments: Recognition and Measurement'', as the Company is an investment company whose business is investing in financial assets with a view to profiting from their total return in the form of interest and changes in fair value. Despite the large holding, under International Accounting Standard 28 ("IAS 28") "Investments in Associates", the fund can hold the investment in Electra shares at fair value through profit or loss rather than as an associate as SIGB, LP is a closed-ended fund.

 

Investments in voting shares and derivative contracts are initially recognised at fair value. The investments in voting shares and derivative contracts are subsequently re-measured at fair value, as determined by the Directors. Unrealised gains or losses arising from the revaluation of investments in voting shares and derivative contracts are taken directly to the Consolidated Statement of Comprehensive Income.

In determining fair value in accordance with IFRS 13 "Fair value Measurement" ("IFRS 13"), investments measured and reported at fair value are classified and disclosed in one of the following categories within the fair value hierarchy:

Level I - An unadjusted quoted price in an active market provides the most reliable evidence of fair value and is used to measure fair value whenever available. As required by IFRS 13, the Group will not adjust the quoted price for these investments, even in situations where it holds a large position and a sale could reasonably impact the quoted price.

 

Level II - Inputs are other than unadjusted quoted prices in active markets, which are either directly or indirectly observable as of the reporting date, and fair value is determined through the use of models or other valuation methodologies.

Level III - Inputs are unobservable for the investment and include situations where there is little, if any, market activity for the investment. The inputs into the determination of fair value require significant management judgment or estimation.

The investments held by the Group at the period end are classified as meeting the definition of Level I (2016: Level I). On disposal of shares or conversion of bonds, cost of investments are allocated on a FIFO basis.

 

e. Revenue recognition

Dividend income is recognised when the Group's right to receive payment has been established. Tax suffered on dividend income for which no relief is available is treated as an expense.

Interest receivable from short-term deposits and investment income are recognised on an accruals basis. Where receipt of investment income is not likely until the maturity or realisation of an investment the investment income is accounted for as an increase in the fair value of the investment.

 

f. Expenses

All expenses are accounted for on an accruals basis. Expenses are charged through the Condensed Consolidated Statement of Comprehensive Income.

 

g. Finance costs

 

Finance costs include interest on bank loans and amortised transaction costs. Finance costs are recognised using the effective interest method.

 

h. Prepaid expenses and trade receivables

 

Trade and other receivables are initially recognised at fair value. A provision for impairment of trade receivables is established when there is objective evidence the Group will not be able to collect all amounts due according to the original terms of the receivables.

 

i. Cash and cash equivalents

Cash and cash equivalents comprises cash in hand as well as call and current balances with banks and similar institutions, which are readily convertible to known amounts of cash and are subject to insignificant risk of changes in value. This definition is also used for the Condensed Consolidated Statement of Cash Flows.

j. Trade and other payables

Trade and other payables are initially recognised at fair value and subsequently, where necessary, re-measured at amortised cost using the effective interest method.

k. Financial instruments

Financial instruments and financial liabilities are recognised in the Group's Condensed Consolidated Statement of Financial Position when the Group becomes a party to the contractual provisions of the instrument.

l. Segmental reporting

As the Group invests in one investee company, there is no segregation between industry, currency or geographical location. No further disclosures have been made in conjunction with IFRS 8 Operating Segments as it is deemed not to be applicable.

 

m. Incentive allocation

The incentive allocation is accounted for on an accruals basis and the calculation is disclosed in Note 15. The incentive is payable to Non-Controlling Interests and therefore recognised in the Condensed Consolidated Statement of Changes in Equity rather than recognised as an expense in the Condensed Consolidated Statement of Comprehensive Income.

2. Comprehensive income

The consolidated comprehensive income has been arrived at after charging:

1 January 2017

to 30 June 2017

1 January 2016 to 30 June 2016

1 January 2016 to 31 December 2016

£

£

£

Directors' fees

58,750

55,000

110,000

Auditor's remuneration - Audit

13,379

13,175

28,200

Auditor's remuneration - interim review

14,600

14,600

14,600

 

In addition to the audit and half-yearly review related remuneration above a further £13,742 was due to the Auditor in relation to Tax compliance services (31 December 2016: £27,748).

 3. Tax on ordinary activities

The Company has been granted exemption from income tax in Guernsey under the Income Tax (Exempt Bodies) (Bailiwick of Guernsey) Ordinance 1989, and is liable to pay an annual fee (currently £1,200) under the provisions of the Ordinance. As such it will not be liable to income tax in Guernsey other than on Guernsey source income (excluding deposit interest on funds deposited with a Guernsey bank). No withholding tax is applicable to distributions to Shareholders by the Company.

The Investment Partnership will not itself be subject to taxation in Guernsey. No withholding tax is applicable to distributions to partners of the Investment Partnership.

 

Income which is wholly derived from the business operations conducted on behalf of the Investment Partnership with, and investments made in, persons or companies who are not resident in Guernsey will not be regarded as Guernsey source income. Such income will not therefore be liable to Guernsey tax in the hands of non-Guernsey resident limited partners.

 

Dividend income is shown gross of any withholding tax.

 

4. Earnings per share

The calculation of basic and diluted gain per share is based on the return on ordinary activities less total comprehensive income attributable to the Non-Controlling Interest and on there being 314,547,259 weighted average shares in issue. The earnings per share as at 30 June 2017 amounted to a surplus of 12.71 pence (as at 30 June 2016: a deficit of 0.65 pence and as at 31 December 2016: 33.67 pence profit).

Date

Shares

Days in issue

Weighted Average Shares

01/01/2017

314,547,259

181

314,547,259

314,547,259

314,547,259

Date of issue

Shares

Days in issue

Weighted Average Shares

01/01/2016

314,547,259

366

314,547,259

314,547,259

314,547,259

 

5. Financial assets at fair value through profit or loss

 

As at 30 June 2017

As at 30 June

2016

As at 31 December 2016

£

£

£

Opening fair value at the beginning of the period/year

545,824,128

426,795,688

426,795,688

Purchases at cost of ordinary shares

356,727

2,405,001

2,441,959

Fair value adjustments

(345,302,046)

(12,298,863)

116,586,481

Closing fair value at the end of the period/year

200,878,809

416,901,826

545,824,128

Percentage holding of Electra

29.90%

28.37%

29.85%

The Board of Directors approved an investment in Electra Private Equity plc ("Electra") which was proposed by SIGB, LP's Investment Manager, Sherborne Investors Management (Guernsey) LLC in December 2013. Electra is a London Stock Exchange listed investment trust focused on private equity investments.

 

As at 31 December 2016, the Group held 11,426,086 shares of Electra. During 2016, the group held no convertible bonds in Electra and received no interest.

 

As at 30 June 2017, the Company held 11,446,086 shares of Electra. In accordance with the Company's investment policy, the Investment Manager does not intend to effect a purchase of shares such that it would be required to make a mandatory bid for the entire share capital of Electra.

 

6. Prepaid Expenses

 

As at 30 June 2017

As at 30 June 2016

As at 31 December 2016

£

£

£

Prepaid directors and officers insurance

7,233

27,500

10,384

Other prepaid expenses

27,122

34,685

17,150

34,355

62,185

27,534

 

7. Dividend Income

 

On 19 January 2017 a dividend from Electra was received for £12,568,695 which was declared on 9 December 2016 payable to shareholders of record on 16 December 2016.

 

On 24 March 2017 Electra declared a Special dividend of 2,612 pence per share, paid on 5 May 2017 to shareholders of record on 7 April 2017 which equates to £298,449,366.

 

On 25 May 2017 Electra declared a second Special dividend of 914 pence per share, paid on 14 July 2017 to shareholders of record on 9 June 2017 which equates to £104,434,426.

 

8. Cash and cash equivalents

 

Cash and cash equivalents comprises cash held by the Group and short term deposits held with various banking institutions. The carrying amount of these assets approximates their fair value.

 

9. Trade and other payables

 

As at 30 June 2017

 

As at 30 June 2016

 

As at 31 December 2016

£

£

£

Professional fees payable

-

-

27,177

Loan interest payable

-

92,787

89,021

Loan commitment fee payable

-

11,098

685

Other payables

124,217

103,736

288,494

124,217

207,621

405,377

 

 

 

 

10. Loan payable

 

As at 30 June 2017

As at 30 June 2016

As at 31 December 2016

£

£

£

Balance at 1 January

20,000,000

19,979,533

19,979,533

Loan Repayment

(20,000,000)

-

-

Amortisation of transaction costs

-

20,467

20,467

-

20,000,000

20,000,000

 

The Facility Agreement had the following main covenants:

 

i. Any dividend received from Electra shall be applied in prepayment of the Loan and accrued interest up to the amount of the dividend.

 

ii. Any disposal proceeds from the sale of Electra shares, debt instruments or relevant derivatives shall be applied in the prepayment of the Loan and accrued interest up to the amount of the disposal proceeds.

 

iii. Any partnership capital injections in SIGB, LP shall be applied in the prepayment of the Loan and accrued interest up to the amount of the capital injections.

 

iv. SIGB, LP is also required to maintain a Loan to Value (LTV) ratio below 50%. An LTV ratio of 50% or higher would entitle the bank to require full or partial prepayment to restore the required LTV ratio. The LTV ratio is the percentage of the Loan, any accrued interest and fees to the value of SIGB, LP's investment in Electra.

 

The Loan to Value ratio was regularly monitored by the Board to ensure that covenants were maintained in accordance with the Facility Agreement. The outstanding borrowings were repaid on 27 February 2017 (£5 million), 11 May 2017 (£15 million) and then the Facility was cancelled.

 

11. Share capital and share premium

 

As at 30 June 2017

As at 30 June 2016

As at 31 December 2016

Consolidated

Consolidated

Consolidated

Authorised share capital

No.

No.

No.

Ordinary Shares of no par value

Unlimited

Unlimited

Unlimited

Issued and fully paid

No.

No.

No.

Ordinary Shares of no par value

314,547,259

314,547,259

314,547,259

 

As at 30 June 2017

As at 30 June 2016

As at 31 December 2016

Consolidated

Consolidated

Consolidated

Share premium account

£

£

£

Share premium account upon issue

302,696,145

302,696,145

302,696,145

Balance at the end of the period/year

302,696,145

302,696,145

302,696,145

 

12. Net asset value per share attributable to the Company

No. of Shares

Consolidated Pence per Share

30 June 2017

Ordinary Shares

Basic and diluted

314,547,259

50.70

30 June 2016

Ordinary Shares

Basic and diluted

314,547,259

121.42

31 December 2016

Ordinary Shares

Basic and diluted

314,547,259

154.99

 

13. Dividends

On 5 April 2017 a dividend of 87.0 pence per share was declared by the Company and was paid on 19 May 2017 to shareholders of record on 18 April 2017 which equated to £273,656,114.

 

On 5 June 2017 the Company declared a dividend of 30.0 pence per share paid on 28 July 2017 to shareholders of record on 23 June 2017 which equates to £94,364,178.

 

14. Subsequent events

Since 30 June 2017, the share price of Electra has decreased from 1,755 pence to 1,690 pence as at 7 August 2017. If this share price was used to value the Electra shares at 30 June 2017, it would have resulted in a decrease in the closing fair value from £200,878,809 to £193,438,853.

 

15. Related party transactions

The Investment Partnership and its General Partner, Sherborne Investors (Guernsey) GP, LLC, have engaged Sherborne Investors Management (Guernsey) LLC to serve as Investment Manager who is responsible for identifying the Selected Target Company, subject to approval by the Board of Directors of the Company, as well as day to day management activities of the Investment Partnership. The Investment Manager is entitled to receive from the Investment Partnership a monthly management fee equal to one-twelfth of 1% of the net asset value of the Investment Partnership, less cash and cash equivalents and certain other adjustments. At the period end, management fees of £2,593,165 (30 June 2016: £2,029,387) had been paid by the Partnership. No balance was outstanding at the period end.

 

One member of Sherborne Investors (Guernsey) GP, LLC is Sherborne Investors LP (part of the non-controlling interest), which also serves as the Special Limited Partner of the Investment Partnership. The Special Limited Partner is entitled to receive an incentive allocation once aggregate distributions to Partners of the Investment Partnership, of which one is the Company, exceed a certain level of capital contributions to the Investment Partnership, excluding amounts contributed attributable to management fees.

 

Sherborne Strategic Fund D, LLC ("SSFD"), an affiliate of the General Partner to the Investment Partnership, subscribed as a limited partner for £15 million of SIGB, LP on 20 May 2015, thereby acquiring a 4.43% capital interest. As at that date the interest was acquired at the net asset value ("NAV") of SIGB, LP on 20 May 2015. Management and incentive fees have been accrued based on the capital interest of the new limited partner since the date of its admission. For Turnaround investments, the incentive allocation is computed at 10% of the distributions to all Partners in excess of 110%, increasing to 20% of the distributions to all Partners in excess of 150% and increasing to 25% of the distributions to all Partners in excess of 200% of capital contributions, excluding amounts contributed attributable to management fees.

 

If after acquiring a shareholding, the share price of the Selected Target Company rises to a level at which further investment and the effort of a Turnaround is, in the Investment Manager's opinion, no longer justified or otherwise no longer presents a viable Turnaround opportunity, the Investment Partnership intends to sell (and distribute the proceeds to the Company) or distribute in kind the holding to the limited partners (in each case after deductions for any costs and expenses and for the Investment Partnership's Minimum Capital Requirements and subject to applicable law and regulation), rather than seeking to join the Board of Directors or otherwise engage with Selected Target company (a "Stake Building Investment").

 

For Stake Building Investments, the incentive allocation is computed at 20% of net returns on the investment of the Investment Partnership, such amount to be payable after each partner in the Investment Partnership has had distributed to it an amount equal to its aggregate capital contribution to the Investment Partnership in respect to the Stake Building Investment (excluding any capital contributions attributable to Management Fees). The Special Limited Partner may waive or defer all or any part of any incentive allocation otherwise due.

 

At the period end, the incentive allocation has been computed based on a Turnaround Investment and amounts to £44,750,727 (30 June 2016: £8,025,112) of which £1,529,081 (30 June 2016: £180,016) relates to SSFD.

 

Each of the Directors (other than the Chairman) receives a fee payable by the Company currently at a rate of £35,000 per annum. The Chairman of the Audit Committee receives £5,000 per annum in addition to such fee. The Chairman receives a fee payable by the Company currently at the rate of £50,000 per annum. Individually and collectively, the Directors of the Company hold no shares of the Company as at 30 June 2017 (31 December 2016: Nil).

 

Sherborne Investors GP, LLC has granted to the Company a non-exclusive licence to use the name "Sherborne Investors" in the UK and the Channel Islands in the corporate name of the Company and in connection with the conduct of the Company's business affairs. The Company may not sub-licence or assign its rights under the Trademark Licence Agreement. Sherborne Investors GP, LLC receives a fee of £20,000 per annum for the use of the licensed name.

 

16. Financial risk factors

 

The Group's investment objective is to realise capital growth from investment in the Selected Target Company, identified by the Investment Manager with the aim of generating significant capital return for Shareholders. Consistent with that objective, the Group's financial instruments mainly comprise of an investment in a Selected Target Company. In addition, the Group holds cash and cash equivalents as well as having trade and other receivables and trade and other payables that arise directly from its operations.

 

Liquidity risk

 

The Group's cash and cash equivalents are placed in demand deposits and short-term money market instruments with a range of financial institutions. The listed investment in Electra could be partially redeemed relatively quickly (within 3 months) should the Group need to meet obligations or pay ongoing expenses as and when they fall due. The following table details the liquidity analysis for financial liabilities at the date of the Condensed Consolidated Statement of Financial Position:

 

As at 30 June 2017

Consolidated

Less than 1 month

1 - 12 months

 

1 -2 years

Total

£

£

£

£

Trade and other payables

-

124,217

-

124,217

-

124,217

-

124,217

 

 

As at 30 June 2016

Consolidated

Less than 1 month

1 - 12 months

 

1 -2 years

Total

£

£

£

£

Trade and other payables

-

207,621

-

207,621

Loan payable

-

20,000,000

-

20,000,000

-

20,207,621

-

20,207,621

 

 

As at 31 December 2016

Consolidated

Less than 1 month

1 - 12 months

 

1 -2 years

Total

£

£

£

£

Trade and other payables

316,356

89,021

-

405,377

Loan payable

-

-

20,000,000

20,000,000

316,356

89,021

20,000,000

20,405,377

 

Credit risk

 

The Company is exposed to credit risk in respect of its cash and cash equivalents, arising from possible default of the relevant counterparty, with a maximum exposure equal to the carrying value of those assets. The Group is exposed to credit risk in respect of its trade receivables and other receivable balances with a maximum exposure equal to the carrying value of those assets. UBS Financial Services Inc. currently has a stand alone credit rating of A- with Standard & Poor's (2016: A- with Standard & Poor's).

Market price risk

 

Market price risk arises as a result of the Group's exposure to the future values of the share price of the Selected Target Company. It represents the potential loss that the Group may suffer through investing in the Selected Target Company.

 

As at 30 June 2017 a +/-20% change in the price of Electra Ordinary Shares would positively or negatively affect the Group's net assets, income and consolidated comprehensive expense for the period, by £40,175,762 (31 December 2016: £109,164,826).

 

Interest rate risk

 

The Group is subject to risks associated with changes in interest rates in respect of interest earned on its cash and cash equivalents. The Group seeks to mitigate this risk by monitoring the placement of cash balances on an ongoing basis in order to maximize the interest rates obtained.

 

As at 30 June 2017

Interest bearing

Less than

1 month

1 month to

3 months

3 months to

1 year

 

 

Over 1 year

Non- interest bearing

Total

£

£

£

£

£

£

Assets

Cash and cash equivalents

5,612,798

-

-

-

-

5,612,798

Investments held at fair value through profit or loss

-

-

-

-

200,878,809

200,878,809

Dividend receivable

-

-

-

-

104,434,426

104,434,426

Prepaid expenses

-

-

-

-

34,355

34,355

Total Assets

5,612,798

-

-

-

305,347,590

310,960,388

Liabilities

Other payables

-

-

-

-

(124,217)

(124,217)

Dividend payable

-

-

-

-

(94,364,178)

(94,364,178)

Total Liabilities

-

-

-

-

(94,488,395)

(94,488,395)

 

 

As at 30 June 2016

Interest bearing

Less than

1 month

1 month to

3 months

3 months to

1 year

 

 

Over 1 year

Non- interest bearing

Total

£

£

£

£

£

£

Assets

Cash and cash equivalents

10,918,336

-

-

-

-

10,918,336

Investments held at fair value through profit or loss

-

-

-

-

416,901,826

416,901,826

Prepaid expenses

-

-

-

-

62,185

62,185

Total Assets

10,918,336

-

-

-

416,964,011

427,882,347

Liabilities

Loan payable

-

-

(20,000,000)

-

-

(20,000,000)

Other payables

-

-

-

-

(207,621)

(207,621)

Total Liabilities

-

-

(20,000,000)

-

(207,621)

(20,207,621)

 

As at 31 December 2016

Interest bearing

Less than

1 month

1 month to

3 months

3 months to

1 year

 

 

Over 1 year

Non- interest bearing

Total

£

£

£

£

£

£

Assets

Cash and cash equivalents

4,852,217

-

-

-

-

4,852,217

Dividend receivable

-

-

-

-

12,568,695

12,568,695

Investments held at fair value through profit or loss

-

-

-

-

545,824,128

545,824,128

Prepaid expenses

-

-

-

27,534

27,534

Total Assets

4,852,217

-

-

-

558,420,357

563,272,574

Liabilities

Loan payable

-

-

-

(20,000,000)

-

(20,000,000)

Other payables

-

-

-

-

(405,377)

(405,377)

Total Liabilities

-

-

-

(20,000,000)

(405,377)

(20,405,377)

As at 30 June 2017, the total interest sensitivity gap for interest bearing items was a surplus of £5,612,798 (30 June 2016: deficit of £9,081,664).

 

As at 30 June 2017, interest rates reported by the Bank of England were 0.25% which would equate to income of £14,032 (30 June 2016: expense of £22,704) per annum if interest bearing assets remained constant. If interest rates were to fluctuate by 0.25%, this would have a positive or negative effect of £14,032 (30 June 2016: £22,704) on the Group's annual income.

 

Capital risk management

 

The capital structure of the Company consists of proceeds raised from the issue of Ordinary Shares. As at 30 June 2017, the Group is not subject to any external capital requirement.

 

The Board of Directors believe that at the date of the Condensed Consolidated Statement of Financial Position there were no material risks associated with the management of the Company's capital.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR QVLFBDVFLBBF
Date   Source Headline
15th Oct 202111:58 amRNSResult of Extraordinary General Meeting
15th Oct 20217:30 amRNSSuspension - Sherborne Investors (Guersey) B Ltd
1st Oct 20217:00 amRNSEGM Notice/Intention to Cancel Admission of Shares
20th Aug 20217:00 amRNSHalf-year Report
17th Aug 20214:41 pmRNSSecond Price Monitoring Extn
17th Aug 20214:35 pmRNSPrice Monitoring Extension
16th Aug 20219:05 amRNSSecond Price Monitoring Extn
16th Aug 20219:00 amRNSPrice Monitoring Extension
1st Jul 202111:24 amRNSHolding(s) in Company
21st Jun 20214:41 pmRNSSecond Price Monitoring Extn
21st Jun 20214:35 pmRNSPrice Monitoring Extension
21st Jun 20217:00 amRNSDividend Declaration
18th Jun 20213:48 pmRNSStatement re Investment in Electra
18th Jun 20213:38 pmRNSHolding(s) in Company
26th May 20215:30 pmRNSResult of AGM
5th May 20217:00 amRNSNotice of AGM
16th Apr 20219:05 amRNSSecond Price Monitoring Extn
16th Apr 20219:00 amRNSPrice Monitoring Extension
16th Apr 20217:00 amRNSAnnual Financial Report
16th Apr 20217:00 amRNSFinal Results
18th Dec 20204:00 pmRNSHolding(s) in Company
18th Nov 20207:00 amRNSHolding(s) in Company
13th Nov 202011:05 amRNSSecond Price Monitoring Extn
13th Nov 202011:00 amRNSPrice Monitoring Extension
20th Aug 20207:00 amRNSHalf-year Report
5th Jun 20204:40 pmRNSSecond Price Monitoring Extn
5th Jun 20204:36 pmRNSPrice Monitoring Extension
3rd Jun 20207:00 amRNSHolding(s) in Company
27th May 20205:23 pmRNSResult of AGM
27th Apr 20205:30 pmRNSNotice of AGM
20th Apr 20207:00 amRNSFinal Results
20th Apr 20207:00 amRNSAnnual Financial Report
17th Dec 20197:00 amRNSDividend Declaration
16th Dec 20197:00 amRNSHolding(s) in Company
13th Dec 20197:00 amRNSHolding(s) in Company
20th Aug 20197:00 amRNSHalf-year Report
4th Jun 20195:48 pmRNSResult of AGM
30th Apr 20194:07 pmRNSNotice of AGM
30th Apr 20197:00 amRNSFinal Results
30th Apr 20197:00 amRNSAnnual Financial Report
6th Mar 20197:00 amRNSDividend Declaration
14th Feb 20195:40 pmRNSHolding(s) in Company
5th Nov 20187:00 amRNSDividend Declaration
8th Aug 20187:00 amRNSHalf-year Report
4th Jun 20187:00 amRNSDividend Declaration
30th May 20187:00 amRNSHolding(s) in Company
22nd May 20184:18 pmRNSResult of AGM
18th Apr 20187:02 amRNSAnnual Financial Report
18th Apr 20187:00 amRNSNotice of AGM
18th Apr 20187:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.